Related Experiment Videos
Interaction between soluble type I receptor for bone morphogenetic protein and bone morphogenetic protein-4
T Natsume1, S Tomita, S Iemura
1Research and Development Center, Nippon Meat Packers, Inc., 3-3 Midorigahara, Tsukuba, Ibaraki 300-26, Japan. natsume@ims.u-tokyo.ac.jp
The Journal of Biological Chemistry
|April 25, 1997
Summary
Researchers expressed and purified a soluble form of the bone morphogenetic protein (BMP) type I receptor. This soluble BMP receptor binds BMP-4 with high affinity, inhibiting cellular responses and aiding in BMP-2/4 research.
Area of Science:
- Biochemistry
- Molecular Biology
- Cell Signaling
Background:
- Bone morphogenetic proteins (BMPs) are crucial signaling molecules in the transforming growth factor-beta superfamily.
- BMPs initiate biological responses by binding to type I and type II serine/threonine kinase receptors, leading to receptor dimerization.
- Understanding BMP signaling pathways is vital for various biological processes, including bone development and regeneration.
Purpose of the Study:
- To develop a tool for studying BMP-2 and BMP-4 signaling.
- To express and purify the extracellular domain of the BMP type I receptor for BMP-2/4.
- To characterize the binding properties and functional activity of the soluble BMP receptor.
Main Methods:
- Large-scale expression and purification of the extracellular domain of the BMP type I receptor using a silkworm expression system.
- Binding assays using BMP-4, activin, and transforming growth factor-beta1 to assess ligand specificity.
- Surface plasmon resonance (SPR) to determine kinetic parameters (association and dissociation rate constants) and affinity.
- Functional assays measuring alkaline phosphatase activity in BMP-responsive cell lines (MC3T3-E1 and ST2).
Main Results:
- A soluble form of the BMP type I receptor (sBMPR) was successfully produced in monomeric form.
- sBMPR demonstrated specific high-affinity binding to BMP-4, with kinetic parameters comparable to the membrane-bound receptor.
- sBMPR effectively inhibited alkaline phosphatase activity in osteoblastic and stromal cell lines, indicating functional antagonism.
- The extracellular domain alone is sufficient for high-affinity BMP-4 binding.
Conclusions:
- The extracellular domain of the BMP type I receptor for BMP-2/4 is sufficient for high-affinity ligand binding.
- The soluble BMP receptor (sBMPR) is a valuable tool for investigating BMP-2/4 functions in vivo.
- This soluble receptor can serve as a substitute for antibodies in BMP-2/4 research, addressing the current lack of suitable high-affinity antibodies.